Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.

Literature DB >> 16426013

Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.

Abstract

New assays for antibodies to deamidated gliadin peptides (DGP) expressing celiac disease-specific epitopes were evaluated using 154 sera previously tested for endomysial immunoglobulin A (IgA) (EMA), transglutaminase IgA (TGA), and conventional gliadin antibodies. DGP antibody results showed 97% concordance with EMA and TGA results. Of 56 sera negative for EMA and TGA but positive for conventional gliadin antibodies, 54 (96%) were negative for DGP antibodies.

Entities: Gene

Mesh：

Substances：

Year: 2006 PMID： 16426013 PMCID： PMC1356631 DOI： 10.1128/CVI.13.1.150-151.2006

Source DB: PubMed Journal: Clin Vaccine Immunol ISSN： 1556-679X

16 in total

Review 1. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?

Authors: Ivor D Hill
Journal: Gastroenterology Date: 2005-04 Impact factor: 22.682

2. Diagnostic value of various serum antibodies detected by diverse methods in childhood celiac disease.

Authors: L Sacchetti; A Ferrajolo; G Salerno; P Esposito; M M Lofrano; G Oriani; M Micillo; F Paparo; R Troncone; S Auricchio; F Salvatore
Journal: Clin Chem Date: 1996-11 Impact factor: 8.327

3. Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors: W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal: Nat Med Date: 1997-07 Impact factor: 53.440

4. Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

Authors: L J Chartrand; J Agulnik; T Vanounou; P A Russo; P Baehler; E G Seidman
Journal: CMAJ Date: 1997-09-01 Impact factor: 8.262

5. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy.

Authors: M Sárdy; U Odenthal; S Kárpáti; M Paulsson; N Smyth
Journal: Clin Chem Date: 1999-12 Impact factor: 8.327

6. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults.

Authors: T Valdimarsson; L Franzen; E Grodzinsky; T Skogh; M Ström
Journal: Dig Dis Sci Date: 1996-01 Impact factor: 3.199

7. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.

Authors: M Aleanzi; A M Demonte; C Esper; S Garcilazo; M Waggener
Journal: Clin Chem Date: 2001-11 Impact factor: 8.327

8. Comparative studies of different gliadin preparations in detecting antigliadin antibodies.

Authors: V Kumar; N Jain; A Lerner; E H Beutner; T P Chorzelski; E Lebenthal
Journal: J Pediatr Gastroenterol Nutr Date: 1986 Sep-Oct Impact factor: 2.839

9. Does cryptic gluten sensitivity play a part in neurological illness?

Authors: M Hadjivassiliou; A Gibson; G A Davies-Jones; A J Lobo; T J Stephenson; A Milford-Ward
Journal: Lancet Date: 1996-02-10 Impact factor: 79.321

10. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.

Authors: Antonio Carroccio; Giustina Vitale; Lidia Di Prima; Nadia Chifari; Salvatore Napoli; Cristina La Russa; Gaspare Gulotta; Maurizio R Averna; Giuseppe Montalto; Serafino Mansueto; Alberto Notarbartolo
Journal: Clin Chem Date: 2002-09 Impact factor: 8.327

18 in total

1. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.

Authors: Umberto Volta; Alessandro Granito; Erica Fiorini; Claudia Parisi; Maria Piscaglia; Georgios Pappas; Paolo Muratori; Francesco B Bianchi
Journal: Dig Dis Sci Date: 2008-06 Impact factor: 3.199

2. Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease.

Authors: Maria Letizia Falini; Luca Elli; Rosita Caramanico; Maria Teresa Bardella; Claudia Terrani; Leda Roncoroni; Luisa Doneda; Fabio Forlani
Journal: Dig Dis Sci Date: 2008-02-28 Impact factor: 3.199

3. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

Authors: Shadi Rashtak; Michael W Ettore; Henry A Homburger; Joseph A Murray
Journal: Clin Gastroenterol Hepatol Date: 2008-03-04 Impact factor: 11.382

4. Coeliac disease screening in children: assessment of a novel anti-gliadin antibody assay.

Authors: Steven T Leach; Brekhna Aurangzeb; Andrew S Day
Journal: J Clin Lab Anal Date: 2008 Impact factor: 2.352

5. Positive deamidated gliadin peptide antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy.

Authors: Miriam Parizade; Bracha Shainberg
Journal: Clin Vaccine Immunol Date: 2010-03-31

Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides.

Review 1. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?

2. Diagnostic value of various serum antibodies detected by diverse methods in childhood celiac disease.

3. Identification of tissue transglutaminase as the autoantigen of celiac disease.

4. Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

5. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy.

6. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA anti-endomysium antibodies? 100% positive predictive value for celiac disease in adults.

7. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.

8. Comparative studies of different gliadin preparations in detecting antigliadin antibodies.

9. Does cryptic gluten sensitivity play a part in neurological illness?

10. Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.

1. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.

2. Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease.

3. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.

4. Coeliac disease screening in children: assessment of a novel anti-gliadin antibody assay.

5. Positive deamidated gliadin peptide antibodies and negative tissue transglutaminase IgA antibodies in a pediatric population: to biopsy or not to biopsy.

Review 6. Serum markers in the clinical management of celiac disease.

7. Assessment of a Test for the Screening and Diagnosis of Celiac Disease.

Review 8. Celiac disease: an underappreciated issue in women’s health.

9. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease.

10. Performance of serology assays for diagnosing celiac disease in a clinical setting.

Review 1. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations?

Review 6. Serum markers in the clinical management of celiac disease.

Review 8. Celiac disease: an underappreciated issue in women&#x2019;s health.

Review 8. Celiac disease: an underappreciated issue in women’s health.